The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

被引:23
|
作者
Li, Qingrong [1 ]
Lin, Liting [2 ]
Zhang, Cong [3 ]
Zhang, Hengguo [4 ]
Ma, Yan [3 ]
Qian, Haisheng [3 ]
Chen, Xu-Lin [5 ]
Wang, Xianwen [3 ]
机构
[1] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China
[2] Anhui Med Univ, Anhui Prov Inst Translat Med, Res & Engn Ctr Biomed Mat, Sch Biomed Engn, Hefei 230032, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Gastroenterol, Div Life Sci & Med, Hefei 230026, Anhui, Peoples R China
[4] Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei 230032, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei 230022, Peoples R China
关键词
Inflammatory bowel disease; Inorganic nanoparticles; Natural product nanomaterials; ROS/RNS; M1; macrophages; TNBS-INDUCED COLITIS; NITRIC-OXIDE; ULCERATIVE-COLITIS; MACROPHAGE POLARIZATION; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; SELENIUM; CURCUMIN; BAICALIN;
D O I
10.1186/s12951-023-02246-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is a growing body of evidence indicating a close association between inflammatory bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), along with an increase in M1 proinflammatory macrophage infiltration during the activation of intestinal inflammation, plays a pivotal role in disrupting intestinal homeostasis in IBD. The overabundance of ROS/RNS can cause intestinal tissue damage and the disruption of crucial gut proteins, which ultimately compromises the integrity of the intestinal barrier. The proliferation of M1 macrophages contributes to an exaggerated immune response, further compromising the intestinal immune barrier. Currently, intestinal nanomaterials have gained widespread attention in the context of IBD due to their notable characteristics, including the ability to specifically target regions of interest, clear excess ROS/RNS, and mimic biological enzymes. In this review, we initially elucidated the gut microenvironment in IBD. Subsequently, we delineate therapeutic strategies involving two distinct types of nanomedicine, namely inorganic nanoparticles and natural product nanomaterials. Finally, we present a comprehensive overview of the promising prospects associated with the application of nanomedicine in future clinical settings for the treatment of IBD (graphic abstract).Graphical AbstractDifferent classes of nanomedicine are used to treat IBD. This review primarily elucidates the current etiology of inflammatory bowel disease and explores two prominent nanomaterial-based therapeutic approaches. First, it aims to eliminate excessive reactive oxygen species and reactive nitrogen species. Second, they focus on modulating the polarization of inflammatory macrophages and reducing the proportion of pro-inflammatory macrophages. Additionally, this article delves into the treatment of inflammatory bowel disease using inorganic metal nanomaterials and natural product nanomaterials
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Fast Disease Progression of Inflammatory Bowel Disease in Pediatric Patients That Require Surgery
    Burstiner, Landen Shane
    Santo, Mariana
    Garcia, Gerardo Diaz
    Reddy, Anvit D.
    Qadir, Nadim A.
    Rai, Oshin
    Stemboroski, Lauren N.
    Nava, Marianny Sulbaran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S):
  • [42] Morphometric analysis of macrophages containing inorganic particles in inflammatory bowel disease
    Mazumder, RN
    Bode, J
    Church, NI
    Lewin, J
    McIntyre, M
    Ghosh, S
    GUT, 2001, 48 : A73 - A73
  • [43] Discovery of bioactive microbial gene products in inflammatory bowel disease
    Zhang, Yancong
    Bhosle, Amrisha
    Bae, Sena
    McIver, Lauren J.
    Pishchany, Gleb
    Accorsi, Emma K.
    Thompson, Kelsey N.
    Arze, Cesar
    Wang, Ya
    Subramanian, Ayshwarya
    Kearney, Sean M.
    Pawluk, April
    Plichta, Damian R.
    Rahnavard, Ali
    Shafquat, Afrah
    Xavier, Ramnik J.
    Vlamakis, Hera
    Garrett, Wendy S.
    Krueger, Andy
    Huttenhower, Curtis
    Franzosa, Eric A.
    NATURE, 2022, 606 (7915) : 754 - +
  • [44] Restriction of dairy products; a reality in inflammatory bowel disease patients
    Lopes, Mirella Brasil
    Rocha, Raquel
    Lyra, Andre Castro
    Oliveira, Vanessa Rosa
    Coqueiro, Fernanda Gomes
    Almeida, Naiade Silveira
    Valois, Sandra Santos
    Santana, Genoile Oliveira
    NUTRICION HOSPITALARIA, 2014, 29 (03) : 575 - 581
  • [45] Discovery of bioactive microbial gene products in inflammatory bowel disease
    Yancong Zhang
    Amrisha Bhosle
    Sena Bae
    Lauren J. McIver
    Gleb Pishchany
    Emma K. Accorsi
    Kelsey N. Thompson
    Cesar Arze
    Ya Wang
    Ayshwarya Subramanian
    Sean M. Kearney
    April Pawluk
    Damian R. Plichta
    Ali Rahnavard
    Afrah Shafquat
    Ramnik J. Xavier
    Hera Vlamakis
    Wendy S. Garrett
    Andy Krueger
    Curtis Huttenhower
    Eric A. Franzosa
    Nature, 2022, 606 : 754 - 760
  • [46] A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets
    Taghipour, Yasamin Davatgaran
    Bahramsoltani, Roodabeh
    Marques, Andre M.
    Naseri, Rozita
    Rahimi, Roja
    Haratipour, Pouya
    Panah, Amin Iran
    Farzaei, Mohammad Hosein
    Abdollahi, Mohammad
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 26 (02) : 229 - 239
  • [47] PANoptosis in intestinal epithelium: its significance in inflammatory bowel disease and a potential novel therapeutic target for natural products
    Zhao, Chuanxiang
    Lin, Shan
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [48] Protective activity of natural products curcumin, Amomum villosum and Hedyotis diffusa in an animal model of Inflammatory Bowel Disease
    Ortiz-Cerda, Tamara
    Hoosen, Laylaa
    Xie, Kangzhe
    Chen, Siqi
    Ahmad, Gulfam
    Chami, Belal
    Wang, Xiasuo
    O'Sullivan, John
    Witting, Paul
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S46 - S46
  • [49] Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
    Duan, Linshan
    Cheng, Shuyu
    Li, Long
    Liu, Yanling
    Wang, Dan
    Liu, Guoyan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease
    Guada, Melissa
    Beloqui, Ana
    Alhouayek, Mireille
    Muccioli, Giulio G.
    del Carmen Dios-Vieitez, Maria
    Preat, Veronique
    Blanco-Prieto, Maria J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 503 (1-2) : 196 - 198